Chiron Real Estate Inc. (XRN)
Valuation Overview•Is Chiron Real Estate Inc. Overvalued or Undervalued?
Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 41/100; weak margins or elevated debt leverage warrant caution.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven by a balanced mix of reliable dividends and share buybacks.
XRN struggles with subpar profitability and pressured margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company demonstrates solid revenue growth (5.5% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 17.6% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $40.3M | +16.3% | +5.5% | +11.5% | +54.6% | |
| EBITDA | $0.00 | — | +4.0% | — | — | |
| Net Income | -$8.9M | -188.0% | — | — | -13.7% | |
| EPS (Diluted) | $-0.67 | -393.5% | — | — | +40.4% | |
| Free Cash Flow | $13.4M | +67.8% | +53.4% | +46.5% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | -1.1% | 55.1% | 66.7% | 78.2% |
| Operating Margin | 17.6% | 27.0% | 28.3% | 27.8% |
| Net Margin | 34.3% | 5.3% | 9.0% | 0.3% |
| FCF Margin | -120.5% | 6.1% | -30.9% | -364.8% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q1'26Latest | $0.07 | $1.10 | +1592.3% | ||
| Q4'25 | $0.16 | $-0.45 | -381.3% | ||
| Q3'25 | $0.03 | $-0.05 | -250.0% | ||
| Q2'25 | $0.05 | $0.79 | +1480.0% | ||
| Q1'25 | $0.01 | $0.52 | +5100.0% | ||
| Q4'24 | $0.07 | $0.15 | +100.0% | ||
| Q3'24 | $0.20 | $-0.05 | -125.0% | ||
| Q2'24 | $0.03 | $0.05 | +100.0% |
Total return is +7.4% (1Y), lagging the benchmark by -2.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +0.3% | -7.3% | — |
| 1Y | +7.4% | -2.3% | +4.6% |
| 3YCAGR | -2.6% | -21.6% | +20.2% |
| 5YCAGR | -9.3% | -18.7% | +22.1% |
| 10YCAGR | +5.4% | -7.7% | — |
The S&P 500 is at 29.9x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Chiron Real Estate Inc. (XRN) valuation, health, and returns.
Based on peer relative multiples, Chiron Real Estate Inc. appears Cheap versus peers compared to industry peers.
Chiron Real Estate Inc. has multiple valuation anchors: Peer Relative Fair Value: $45.16 | Wall Street Analyst Target: $20.92 (implying -37.1% upside). A convergence of these signals offers higher conviction.
Chiron Real Estate Inc. displays fair financial health with a composite quality score of 41/100, supported by a Piotroski F-Score of 3/9, Return on Invested Capital (ROIC) of 3.1%.
Chiron Real Estate Inc. pays a 13.6% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 1.6% buyback yield.
Chiron Real Estate Inc.'s current growth trajectory is Accelerating. The company achieved +16.3% 1Y revenue growth and -393.5% 1Y EPS growth, compared to its 3Y revenue CAGR of +5.5%.
Wall Street consensus is Buy based on 22 analysts, beating EPS expectations in 58% of recent quarters with a 1-quarter streak. The consensus price target represents a -37.1% change from current levels.
Investment risks for Chiron Real Estate Inc. include: -13.2% 1-year max drawdown. Volatility risk is characterized by a beta of 0.53x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.